Status:
RECRUITING
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
Lead Sponsor:
Takeda
Conditions:
Dengue Fever
Eligibility:
All Genders
4+ years
Brief Summary
The main aim of this study is to collect the number and type of medical problems (adverse events) after vaccination with QDENGA in Malaysia and to learn more about such medical problems after vaccinat...
Eligibility Criteria
Inclusion Criteria:
- Participants who have received at least one dose of QDENGA vaccine in Malaysia during the study period.
- Participants or their legally authorized representative (LARs) with a functioning phone number.
Exclusion Criteria:
No exclusion criteria will be applied for this study.
Key Trial Info
Start Date :
September 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 8 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06388785
Start Date
September 26 2024
End Date
May 8 2027
Last Update
June 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiti Malaya
Kuala Lumpur, Kuala Lumpur, Malaysia, 50603
2
Universiti Putra Malaysia
Serdang, Selangor, Malaysia, 43400